4//SEC Filing
Wise John Drayton 4
Accession 0001628280-25-001204
CIK 0001104506other
Filed
Jan 9, 7:00 PM ET
Accepted
Jan 10, 6:45 PM ET
Size
17.8 KB
Accession
0001628280-25-001204
Insider Transaction Report
Form 4
INSMED IncINSM
Wise John Drayton
Chief Commercial Officer
Transactions
- Award
Stock Option (right to buy)
2025-01-08+31,930→ 31,930 totalExercise: $65.72Exp: 2035-01-08→ Common Stock (31,930 underlying) - Sale
Common Stock
2025-01-07$65.98/sh−10,000$659,800→ 122,492 total - Sale
Common Stock
2025-01-10$65.40/sh−287$18,770→ 125,562 total - Exercise/Conversion
Stock Option (right to buy)
2025-01-07−10,000→ 0 totalExercise: $16.07Exp: 2025-01-08→ Common Stock (10,000 underlying) - Sale
Common Stock
2025-01-07$65.87/sh−2,908$191,550→ 119,584 total - Sale
Common Stock
2025-01-08$66.21/sh−392$25,954→ 119,192 total - Award
Common Stock
2025-01-08+6,657→ 125,849 total - Exercise/Conversion
Common Stock
2025-01-07$16.07/sh+10,000$160,700→ 132,492 total
Footnotes (8)
- [F1]This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
- [F2]Includes 835 shares acquired through the Company's 2018 Employee Stock Purchase Plan.
- [F3]Shares sold to satisfy tax withholding obligations upon the vesting of Restricted Stock Units (RSUs) and to cover related broker fees.
- [F4]This is the weighted average sales price representing 2,908 shares sold at prices ranging from $65.84 to $65.93 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
- [F5]Represents RSUs, each representing a contingent right to receive one share of Common Stock, granted pursuant to the Company's Amended and Restated 2019 Incentive Plan, as amended. The RSUs vest as follows: 25% on the first day of the first month following the first anniversary of the date of grant (the Initial Vesting Date) and 25% on each anniversary of the Initial Vesting Date until fully vested.
- [F6]Each RSU was granted on January 8, 2025 for no consideration.
- [F7]The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable.
- [F8]These stock options were granted under the Company's Amended and Restated 2019 Incentive Plan, as amended. The options become exercisable based on the following vesting schedule: 25% vest on the Initial Vesting Date and an additional 12.5% vest every six months thereafter until fully vested.
Documents
Issuer
INSMED Inc
CIK 0001104506
Entity typeother
Related Parties
1- filerCIK 0001930805
Filing Metadata
- Form type
- 4
- Filed
- Jan 9, 7:00 PM ET
- Accepted
- Jan 10, 6:45 PM ET
- Size
- 17.8 KB